IndraLab

Statements

CBX2 binds USP33. 1 / 1

| 1

sparser

"These findings elucidate the mechanism by which USP33 augments ovarian cancer progression through the stabilization of CBX2, underscoring the USP33-CBX2 axis as a promising therapeutic target in ovarian cancer management."

39256572

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

CBX2 binds USP33. 1 / 1

INDRA sources:

Databases

Reading